New Findings from Yale University in the Area of Seborrheic Dermatitis Described (640 - Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic...).

The article discusses recent research from Yale University on the local tolerability of topical roflumilast in treating seborrheic dermatitis, psoriasis, and atopic dermatitis. Topics discussed include the importance of minimizing skin irritation for patient adherence, the favorable tolerability results observed in Phase 3 trials, and the effectiveness of roflumilast formulations in sensitive skin areas.